Earnings History Data for Iovance Biotherapeutics, Inc. (IOVA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. is a biopharmaceutical company. It focused on the development and commercialization of cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. Iovance Biotherapeutics Inc., formerly known as Lion Biotechnologies Inc., is based in SAN CARLOS, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | AH | IOVA | Iovance Biotherapeutics, Inc. | 3,540 | -0.28 | -0.31 | -0.46 | Iovance Biotherapeutics GAAP EPS of -$0.28 beats by $0.02, revenue of $58.6M beats by $4.78M [11/7/2024 4:06 PM] |
10.60 | -1.68 (-13.68%) |
10.78 | -1.50 (-12.21%) |
3.76 - 18.33 | 25,873,875 | 6,140,000 | 320,683 | ||
|
||||||||||||||||||
| 08-08-2024 | AH | IOVA | Iovance Biotherapeutics, Inc. | 2,170 | -0.34 | -0.37 | -0.47 | Iovance Biotherapeutics GAAP EPS of -$0.34 beats by $0.01, revenue of $31.1M beats by $6.54M [8/8/2024 4:13 PM] |
9.88 | 1.93 (24.37%) |
9.35 | 1.41 (17.76%) |
3.21 - 18.33 | 20,484,155 | 7,350,000 | 1,421,914 | ||
| 09-05-2024 | AH | IOVA | Iovance Biotherapeutics, Inc. | 3,900 | -0.42 | -0.45 | -0.50 | Iovance Biotherapeutics reports Q1 results [5/9/2024 4:03 PM] |
11.01 | -2.44 (-18.18%) |
12.99 | -0.46 (-3.42%) |
3.21 - 18.33 | 18,216,130 | 4,350,000 | 182,427 | ||
| 28-02-2024 | AH | IOVA | Iovance Biotherapeutics | 4,036 | -0.45 | -0.44 | 0.00 | Iovance Biotherapeutics GAAP EPS of -$0.45 misses by $0.01, revenue of $0.48M misses by $0.92M [2/28/2024 4:15 PM] |
15.89 | -1.54 (-8.81%) |
16.21 | -1.22 (-7.00%) |
3.21 - 18.33 | 15,248,054 | 23,780,000 | 320,597 | ||
| 07-11-2023 | AH | IOVA | Iovance Biotherapeutics, Inc. | 1,040 | -0.46 | -0.46 | -0.63 | Iovance Biotherapeutics GAAP EPS of -$0.46 misses by $0.01 [11/7/2023 4:14 PM] |
4.17 | -0.15 (-3.36%) |
4.42 | 0.10 (2.31%) |
3.21 - 9.36 | 10,401,139 | 5,280,000 | 28,052 | ||
| 08-08-2023 | AH | IOVA | Iovance Biotherapeutics, Inc. | 1,630 | -0.47 | -0.81 | -0.63 | Iovance Biotherapeutics GAAP EPS of -$0.47 beats by $0.38, revenue of $0.24M [8/8/2023 4:17 PM] |
7.58 | 0.45 (6.23%) |
7.20 | 0.06 (0.84%) |
5.28 - 13.32 | 6,793,353 | 3,760,000 | 7,303 | ||
| 09-05-2023 | AH | 4:00 PM ET (May 9) |
IOVA | Iovance Biotherapeutics, Inc. | 1,520 | -0.50 | -0.84 | -0.58 | Iovance Biotherapeutics GAAP EPS of -$0.50 beats by $0.26 [5/9/2023 4:05 PM] |
7.67 | 0.31 (4.21%) |
7.50 | 0.14 (1.90%) |
5.28 - 15.65 | 6,389,581 | 4,070,000 | 14,419 | |
| 28-02-2023 | AH | 4:00 PM ET (Feb 28) |
IOVA | Iovance Biotherapeutics, Inc. | 1,170 | -0.64 | -0.64 | -0.63 | Iovance Biotherapeutics GAAP EPS of -$0.64 in-line [2/28/2023 4:10 PM] |
7.29 | 0.0 (0.00%) |
7.47 | 0.18 (2.47%) |
5.42 - 18.73 | 2,181,962 | 3,030,000 | 4,242 | |
| 03-11-2022 | AH | 4:00 PM ET (Nov 3) |
IOVA | Iovance Biotherapeutics, Inc. | 1,480 | -0.63 | -0.64 | -0.55 | Iovance Biotherapeutics GAAP EPS of -$0.63 beats by $0.01 [11/3/2022 4:03 PM] |
8.88 | 0.36 (4.16%) |
8.53 | 0.0 (0.00%) |
6.18 - 26.13 | 2,376,946 | 1,870,000 | 24,452 | |
| 04-08-2022 | AH | 4:00 PM ET (Aug 4) |
IOVA | Iovance Biotherapeutics, Inc. | 1,850 | -0.63 | -0.60 | -0.53 | Iovance Biotherapeutics GAAP EPS of -$0.63 misses by $0.02 [8/4/2022 4:11 PM] |
12.18 | -0.36 (-2.87%) |
12.18 | 0.0 (0.00%) |
6.18 - 27.96 | 4,089,689 | 2,320,000 | 12,387 | |
| 05-05-2022 | AH | 4:00 PM ET (May 5) |
IOVA | Iovance Biotherapeutics, Inc. | 2,580 | -0.58 | -0.64 | -0.51 | Iovance Biotherapeutics GAAP EPS of -$0.58 beats by $0.06 [5/5/2022 4:11 PM] |
14.46 | -0.37 (-2.49%) |
14.83 | 0.0 (0.00%) |
12.18 - 30.82 | 2,345,295 | 1,740,000 | 6,435 | |
| 24-02-2022 | AH | 4:00 PM ET (Feb 24) |
IOVA | Iovance Biotherapeutics, Inc. | 2,430 | -0.63 | -0.56 | -0.47 | Iovance Biotherapeutics GAAP EPS of -$0.63 misses by $0.07 [2/24/2022 4:21 PM] |
15.15 | 0.30 (2.02%) |
0.0 | 0.0 (0.00%) |
13.28 - 40.15 | 1,278,476 | 1,590,000 | 0 | |
| 04-11-2021 | AH | 4:00 PM ET (Nov 4) |
IOVA | Iovance Biotherapeutics, Inc. | 3,840 | -0.55 | -0.52 | -0.40 | Iovance Biotherapeutics EPS misses by $0.03 [11/4/2021 4:04 PM] |
24.94 | 0.43 (1.75%) |
24.00 | -0.51 (-2.08%) |
15.88 - 54.21 | 1,937,565 | 1,520,000 | 63,606 | |
|
||||||||||||||||||
| 05-08-2021 | AH | 4:00 PM ET (Aug 5) |
IOVA | Iovance Biotherapeutics, Inc. | 3,400 | -0.53 | -0.51 | -0.47 | Iovance Biotherapeutics EPS misses by $0.02 [8/5/2021 4:22 PM] |
23.62 | -0.30 (-1.27%) |
24.10 | 0.17 (0.71%) |
15.88 - 54.21 | 2,118,445 | 1,640,000 | 20,586 | |
| 06-05-2021 | AH | 4:00 PM ET (May 6) |
IOVA | Iovance Biotherapeutics, Inc. | 4,830 | -0.51 | -0.48 | -0.55 | Iovance Biotherapeutics EPS misses by $0.03 [5/6/2021 4:02 PM] |
28.52 | -0.09 (-0.31%) |
28.52 | 0.0 (0.00%) |
24.67 - 54.21 | 2,565,612 | 1,970,000 | 15,062 | |
|
||||||||||||||||||
| 25-02-2021 | AH | 4:00 PM ET (Feb 25) |
IOVA | Iovance Biotherapeutics, Inc. | 6,920 | -0.47 | -0.46 | -0.50 | Iovance Biotherapeutics EPS misses by $0.03 [2/25/2021 4:05 PM] |
37.43 | 0.92 (2.52%) |
36.22 | -0.29 (-0.79%) |
18.70 - 54.21 | 2,285,719 | 1,296,782 | 3,121 | |
|
||||||||||||||||||
| 05-11-2020 | AH | 4:00 PM ET (Nov 5) |
IOVA | Iovance Biotherapeutics, Inc. | 5,430 | -0.40 | -0.46 | -0.40 | Iovance Biotherapeutics EPS beats by $0.06 [11/5/2020 4:20 PM] |
40.38 | -0.04 (-0.10%) |
40.37 | -0.05 (-0.12%) |
18.70 - 41.60 | 871,151 | 972,329 | 600 | |
|
|
||||||||||||||||||
| 06-08-2020 | AH | 4:00 PM ET (Aug 6) |
IOVA | Iovance Biotherapeutics, Inc. | 4,550 | -0.47 | -0.52 | -0.38 | Iovance Biotherapeutics EPS beats by $0.05 [8/6/2020 4:05 PM] |
30.24 | -0.91 (-2.92%) |
30.98 | -0.17 (-0.55%) |
17.67 - 41.49 | 611,606 | 958,015 | 1,057 | |
|
|
||||||||||||||||||
| 05-05-2020 | AH | 4:00 PM ET (May 5) |
IOVA | Iovance Biotherapeutics, Inc. | 4,060 | -0.55 | -0.53 | -0.30 | Iovance Biotherapeutics EPS misses by $0.03 [5/5/2020 4:33 PM] |
32.66 | 0.41 (1.27%) |
31.25 | -1.41 (-4.32%) |
10.15 - 39.00 | 1,668,060 | 1,802,218 | 5,319 | |
|
|
||||||||||||||||||